Gnosis by Lesaffre: Press Releases

A new book highlights the role of the innovative folate 5-MTHF in health
Tuesday, June 09, 2020 Born from the collaboration between two important key scientists of the world of folate and of the one-carbon metabolism, Prof. D. Ingrosso and Prof. A. Perna, Gnosis by Lesaffre is...

Quatreflora™ Biootic, The natural and innovative probiotic approach to vaginosis
Monday, May 18, 2020 Vaginal infections affect 70% of women during their lifetimes and account for millions of annual doctors’ visits.

Gnosis by Lesaffre issues new marketing tools for Quatrefolic and Phosphocomplex ingredients
Wednesday, March 04, 2020 Gnosis by Lesaffre continues its project of bringing end-manufacturers and consumers to the deep science aspects of its ingredients, outlining benefits and the most recent data...

Normalising hyperhomocysteinemia: Quatrefolic® Focus – the case of infertility [1]
Wednesday, February 19, 2020 Very recently, a publication of Clement et al. has recommended that couples with a long history of infertility should be analysed for MTHFR polymorphism and homocysteine.

New clinical study showing efficacy of the probiotic ibSium on intestinal comfort presented at coming Probiota in Dublin
Friday, February 07, 2020 New clinical study showing efficacy of the probiotic ibSium on intestinal comfort presented at coming Probiota in Dublin.

New report of ConsumerLab on vitamin K2 supplements: the vitaMK7 gets positive results
Tuesday, December 17, 2019

First Science UP about Quatrefolic: ACTIVE FOLATE and the ELDERLY
Wednesday, October 16, 2019 Gnosis by Lesaffre has recently issued a new marketing tool under the name of Science Up, to provide scientific updates on its innovative ingredients, with a new edition dedicated...

Gnosis by Lesaffre at FIA 2019: experience the daily menu created with our ingredients
Wednesday, August 28, 2019 From 11-13 September Gnosis by Lesaffre will showcase at Food Ingredients Asia 2019, the leading food and beverage platform in the Southeast Asian regions.

Gnosis Bioresearch S.A. obtains certification for Adogran ingredient
Wednesday, July 24, 2019 We are really proud to inform that the GMP+ Feed Certification scheme – module Feed Safety Assurance issued from the Schouten Certification B.V. and received last February by...

Gnosis by Lesaffre unveils new website dedicated to Lynside ProteYn, the alternative source of complete protein from yeast
Wednesday, July 24, 2019 Gnosis by Lesaffre is raising awareness about Lynside ProteYn with the launch of a new dedicated website.

Successful speech about Quatrefolic in China at the New Nutrition Business & Leading Summit 2019
Tuesday, June 11, 2019 On 3 June Gnosis by Lesaffre participated in the New Nutrition Business & Leading Summit 2019 in China. The Italian company had the opportunity to introduce the features of Quatrefolic,...

Why Active Folate 5-MTHF is an ally in Sport Nutrition
Tuesday, May 28, 2019 Sport supplements, when formulated to fit the natural functions of the body, may help to promote adaptation to training, improve performance and recovery, prevent injury, and can...

Gnosis by Lesaffre unveils new scientific paper and new website dedicated to Quatreflora, proprietary yeast to support vaginal health
Wednesday, May 22, 2019 The Gnosis now range includes Quatreflora, an innovative approach to women's intimate health backed by strong science and clinical research.

Vitamin K2 stability linked with purity Profile, says a published study
Monday, April 29, 2019 A just released study in the "Molecules" Journal shows that higher purity profile of vitamin K2 as MK7 correlates with enhanced stability in formulations and this could explain...

Gnosis by Lesaffre unveils new website dedicated to ibSium, breakthrough beneficial live yeast supporting complete intestinal comfort
Tuesday, April 09, 2019 Gnosis by Lesaffre (formerly Lesaffre Human Care), business unit of Lesaffre Group dedicated to nutrition, health and personal care businesses, is raising awareness about ibSium with...

Gnosis by Lesaffre presents its new corporate logo and the wide range of products
Friday, March 29, 2019 Gnosis by Lesaffre, the new business unit of Lesaffre recently born from the merge of Gnosis SpA and Lesaffre Human Care, is proud to announce and present its new corporate logo and...

Gnosis Bioresearch S.A. is now certified to produce ingredients for animal nutrition
Monday, March 25, 2019 Gnosis by Lesaffre is proud to communicate that its manufacturing site, Gnosis Bioresearch S.A. Sant'Antonino Operations (Switzerland), following the inspection held on December 2018...

SAMe (S-Adenosyl-methionine): a new book emphasises non-stop innovation in human health
Thursday, February 21, 2019 An engaging and insightful book written by Professor Teodoro Bottiglieri - “SAMe: Metabolic Function and Health Benefits”, has appeared in these days on the panorama of...

SAMe presentation and special book of Professor Teodoro Bottiglieri at the next Integrative Health Symposium
Wednesday, February 13, 2019 At the Integrative Healthcare Symposium (IHS) professor Teodoro Bottiglieri will give a presentation about the importance of SAMe

Discover the “SPREADING KNOWLEDGE PROJECT”
Tuesday, January 08, 2019 Gnosis by Lesaffre celebrates the year just pass away with a new video with the major and successful events, thanking all those who contribute to spread science and knowledge about...

Mild and moderate depressive symptoms: new data finds Adonat-SAMe helpful
Monday, November 26, 2018 A new clinical study shows the effects of a S-AdenosylMethionine-based dietary supplement (SAMe 200 mg/die - Adonat SAMe ingredient manufactured by the biotech company Gnosis SpA -...

Gnosis increases its production capacity with a new fermenter
Tuesday, November 20, 2018 Gnosis is glad to present R-1004, the new fermentation line that started operation at Pisticci manufacturing plant in the beginning of November. It is entirely dedicated to the...

Benefits Overview of Emothion, the effective - IN BODY - form of glutathione
Monday, November 12, 2018 Gnosis is proud to announce the release of a new chart showing an overview of the benefits of Emothion in five different fields of application.

Join our Newsletter platform to build your knowledge!
Thursday, October 18, 2018 Always stay up-to-date on Gnosis and its products, and keep informed about the latest studies and researches carried out.

Gnosis and CPhI Worldwide: successful exhibition for pharmaceutical and nutraceutical effective ingredients
Thursday, October 18, 2018 CPhI, the worldwide pharmaceutical exhibition held in Madrid this week, closed its doors with a large success for Gnosis on show together with Lesaffre Human Care (LHC).

VitaMK7 fits to clean label ingredient profile
Thursday, October 18, 2018 VitaMK7, the vitamin K2 as Menaquinone-7 (MK7), produced naturally from the patented biofermentation process of the Bacillus subtilis natto, offers a CLEAN LABEL and an...

Fermented VitaMK7, the only with four years of stability
Thursday, October 18, 2018 The primary purity of an active ingredient affects its stability, because it minimises the cross-reactions with other substances included in the material offered, even in very...

Great success in China for Gnosis: vitamin K2 workshop in Guangzhou exceeded attendees' expectations
Tuesday, September 18, 2018 With great interest from the audience, the first Gnosis workshop in China on Vitamin K2 – vitaMK7®: beyond vitamin K2. Reveal on purity, stability & health benefits – held in...

Gnosis’ first workshop on vitamin K2 in China: “VitaMK7®: beyond vitamin K2. Reveal on purity, stability & health benefits”
Friday, September 07, 2018 Gnosis announces its first workshop on vitamin K2 in China, entitled “vitaMK7: beyond vitamin K2. Reveal on purity, stability & health benefits”. The event will be held on 13...

Polymorphism of MTHFR 677CC linked with CAD, says new study
Friday, July 27, 2018 A newly published Indian study investigated the role of genetic polymorphism of methylenetetrahydrofolate reductase (MTHFR) as a potential genetic marker associated with Coronary...

New chart on stability of vitamin K2 as vitaMK7®
Thursday, July 26, 2018 Gnosis is pleased to share with its partners and clients the results taken from the "Stability Study Project", which was carried out on the vitaMK7® ingredient, when it is conducted...

Gnosis speaks your language to feel closer to you
Tuesday, July 24, 2018 Gnosis offers its customers a complete and personalised support, ranging from scientific to marketing, with the purpose of helping their business.

Methylation-Homocysteine: Gnosis’ new infographic explains the topic
Friday, July 20, 2018 Gnosis new infographic about Methylation-Homocysteine.

Quatrefolic® the active folate and pregnancy outcome vs folic acid
Friday, July 13, 2018 A recently published case series study has evaluated the effect of 5-MTHF glucosamine salt (Quatrefolic®) in couples with recurrent miscarriages, lasting for at least four years.

New leaflet released by Gnosis on Sport Nutrition
Thursday, July 05, 2018 Gnosis believes in promoting and sustaining a healthy lifestyle in its every shade. Following its inspiration, the company has just released a new leaflet on Sport Nutrition, one of...

Vegetarian Chondroitin Sulfate: Prof. Volpi marks the turning point with Mythocondro®
Thursday, July 05, 2018 Nicola Volpi, Associate Professor of Biochemistry at the University of Modena and Reggio Emilia (Italy), has recently led a group of scientists in the human evaluation of...

Gnosis shares the new chart of Mythocondro® showing its relevant advantages
Thursday, July 05, 2018 Extensive human clinical trials demonstrate that Chondroitin Sulfate (CS) is an active ingredient with multiple benefits, as it protects joints and cartilage from deterioration and...

Gnosis releases the virtual tour of the biotechnology manufacturing facility of Pisticci
Tuesday, May 29, 2018 We are pleased to present you the new video of Pisticci Operations, Gnosis most recent production site.

New clinical study on Mythocondro®: effective in the treatment of moderate knee osteoarthritis
Friday, May 11, 2018 Gnosis is excited to announce that the new clinical study on Mythocondro® - assessed to investigate the efficacy of the Non-Animal Chondroitin Sulfate in the treatment of moderate...

Gnosis’ customer support never stops and runs close to its partners and clients
Wednesday, May 02, 2018 Following the lively interest aroused by the newly released White Paper on Adonat®, Lorena Carboni, Product Support Specialist in Gnosis, held a thorough educational session with...

Mythocondro®, the Non-Animal Chondroitin Sulfate: new study on human preliminary results
Wednesday, May 02, 2018 During next edition of Vitafoods Europe - the tradeshow taking place from 15 to 17 May 2018 in Palexpo (Geneva) - Gnosis will exclusively disclose the latest clinical results...

Gnosis shares new video on YouTube: Know why VitaMK7® is the PURE-ACTIVE vitamin K2 as MK7
Wednesday, May 02, 2018 Gnosis is ready to show to international community the entire process leading to the manufacturing of VitaMK7®, the only European fermented vitamin K2 as MK7 produced exclusively...

Newly Gnosis Adonat® white paper is ready to be browsed
Monday, April 16, 2018 Gnosis is glad to inform that Adonat® WhitePaper, which is dedicated to the Gnosis commercially stable form of S-Adenosyl-L-methionine (SAMe), has been recently implemented with...

Quatrefolic® gains approval in Taiwan as a non-traditional food ingredient
Friday, April 06, 2018 Gnosis is pleased to announce that Quatrefolic®, the biologically active form of the naturally-occurring predominant form of folate, has been approved as a non-traditional food...

Quatrefolic® and its multiple properties for the protection of memory
Tuesday, March 27, 2018 Folate, such as the metabolic active form Quatrefolic® is among the nutrients with potential significance for retention of cognitive capabilities and prevention of cognitive decline...

DuPont and Inbiose celebrate EU regulatory approval of their first human milk oligosaccharide ingredient for infant formula
Tuesday, March 27, 2018 DuPont Nutrition & Health and Inbiose meet regulatory requirements to bring 2’-Fucosyllactose to the European market.

Dedicated video to celebrate the event 'Innovation in Vitamins: Vitamin K2 and Folate ultimate updates'
Friday, March 23, 2018 A dedicated video about the special event on "Innovation in Vitamins: Vitamin K2 and Folate ultimate updates", held in Vietnam in January, has been just released, in order to inform...

Gnosis announces Biootic® Saccharomyces boulardii is officially a 'Non-GMO Project Verified Product'
Thursday, March 22, 2018 We are proud to announce that our product Biootic® has successfully passed the Non-GMO Project’s Product Verification Programme, designed to assess compliance with the Non-GMO...

Great interest in Prof. Teodoro Bottiglieri’s speech on folate and SAMe at the Integrative Healthcare Symposium
Thursday, March 01, 2018 During the Integrative Healthcare Symposium held last week in New York, Professor Teodoro Bottiglieri – director of the Center of Metabolomics at Baylor Research Institute in Texas –...

New vitaMagazine fact sheet: The key focus on MK7 Reliable Supply Chain
Wednesday, February 21, 2018 Although the origin of the raw materials is of paramount importance for the manufacture of high quality products, this factor alone is not sufficient to guide in the selection of the...

Gnosis launches new mobile-friendly corporate website
Tuesday, February 13, 2018 Gnosis is proud to announce the launch of its new corporate website with a new intuitive and user-friendly graphic design that allows the optimum pleasure from any device, in every...

New perspectives of S-Adenosylmethionine (SAMe) in CNS
Tuesday, January 30, 2018 An interesting recent review of S-Adenosyl-methionine (SAMe), published at the end of 2017, has provided a broad perspective on the role, efficacy and safety of SAMe in the treatment...

MYTHOCONDRO®, the only vegetarian chondroitin sulfate, gains Novel Food EU Approval
Tuesday, December 12, 2017 On November 24th, the Minister for Medical Care (The Netherlands) sent an Official Notice to Gnosis with the approval for the placing of Chondroitin Sulfate (Mythocondro®) on the...

Gnosis continues to support customers on MK7 quality open questions
Thursday, November 30, 2017 In order to have a K2 finished product that can distinguish itself from its competitors, it should be chosen a pure and stable MK7 ingredient, to minimize the cross reactions with...

Quatrefolic®: the new food nutritional fortification substance authorised in China
Friday, November 10, 2017 With an official notification [2017, No. 8] issued on October 20th 2017 by the National Health and Family Planning Commission of the PRC (former Ministry of Health of the...

Folate and mood: a powerful bond!
Thursday, November 02, 2017 Supplementation with Quatrefolic®, the “innovactive” folate, may be useful for protection against mood impairment.

50 nutraceutical key opinion leaders hosted in Gnosis K2 Global Event
Thursday, November 02, 2017 Gnosis had the pleasure to host 50 Turkish nutraceutical key opinion leaders in its manufacturing site of Pisticci on 19 October.

Gnosis, the One-Carbon Metabolism dedicated company, supports the International Conference ICHOCM 2017
Thursday, May 25, 2017 New highlights on folate MTHFR polymorphism from ICHOCM 2017. Really interesting scientific data have been presented at the just closed 11th International Conference on Homocysteine...

Mythocondro® obtains GRAS status by FDA
Thursday, April 06, 2017 Gnosis S.p.A. announced that the US Food and Drug Administration (FDA) has positively finalised its determination that Mythocondro®, the Non-Animal Chondroitin Sulfate, has a granted...

Mythocondro shortlisted as Best New Ingredient at NutraIngredients Awards 2017
Thursday, March 23, 2017 Mythocondro, the Non-Animal Chondroitin Sulfate of fermentation origin, is a finalist at the NutraIngredients Awards 2017 in the Healthy Ageing category.

Mythocondro®, the vegetarian alternative of chondroitin sulfate: the website is up and running!
Friday, March 03, 2017 Mythocondro® has a brand-new user friendly DEDICATED WEBSITE designed to provide all of the featured aspects of this pioneering vegetarian alternative of CS.

Gnosis' YOUTUBE channel opens a window to its specialties, Quatrefolic® and Mythocondro®
Thursday, February 02, 2017 Gnosis has just launched a new YouTube channel (Gnosis-bio) to share knowledge and scientific backing about its ingredients, unlock not very well-known and often critical aspects of...

Quatrefolic® and the elderly: challenges and opportunities
Thursday, February 02, 2017 Gnosis steadily invests in science to discover and raise awareness of what is going on in the world of folates, emphasising scientifically proven aspects of the role of...

Gnosis obtains US FDA approval for its API manufacturing facility in Pisticci
Wednesday, May 21, 2014 Gnosis has announced US FDA approval for its API manufacturing facility in Pisticci, Italy. The Pisticci facility also received quality approval from the Italian Ministry of Health...

Gnosis achieves US FDA approval for its manufacturing facility in Switzerland
Friday, April 11, 2014 Gnosis is pleased to announce that its manufacturing facility based in Sant’Antonino, Switzerland, has received US Food and Drug Administration (FDA) approval.


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.